Bo Chen, Founder of Keymed Biosciences

Bo Chen is the founder of Keymed Biosciences. Latest round: IPO. Backed by OrbiMed, Bain Capital.

About Bo Chen

Bo Chen is the Chairman, Executive Director, and CEO of Keymed Biosciences, a company he founded in 2016. An expert in antibody drug discovery and development with over 20 years of experience, he led Keymed Biosciences to be listed on the main board of the Hong Kong Stock Exchange in July 2021. Previously, he founded Wuhan Huaxin Kangyuan Biopharma Co., Ltd. and Shanghai Junshi Biosciences Co., Ltd., where he was instrumental in developing groundbreaking innovative medicines such as the first domestically-developed PD-1 antibody toripalimab and the first domestically-developed IL-4α humanized monoclonal antibody, Stapokibart Injection, which was approved and launched in September 2024.

Bo Chen at a glance

More founder profiles (28)

Browse related founder lists (3)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades